loading
Schlusskurs vom Vortag:
$9.98
Offen:
$9.99
24-Stunden-Volumen:
8,000
Relative Volume:
0.12
Marktkapitalisierung:
$123.97M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.89M
KGV:
-14.05
EPS:
-0.7
Netto-Cashflow:
$-6.48M
1W Leistung:
+5.30%
1M Leistung:
-3.77%
6M Leistung:
-29.40%
1J Leistung:
-25.04%
1-Tages-Spanne:
Value
$9.6485
$10.12
1-Wochen-Bereich:
Value
$9.09
$10.86
52-Wochen-Spanne:
Value
$8.06
$18.75

Greenwich Lifesciences Inc Stock (GLSI) Company Profile

Name
Firmenname
Greenwich Lifesciences Inc
Name
Telefon
203-434-3290
Name
Adresse
3992 BLUEBONNET DR, BUILDING 14, STAFFORD
Name
Mitarbeiter
8
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-08
Name
Neueste SEC-Einreichungen
Name
GLSI's Discussions on Twitter

Vergleichen Sie GLSI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
GLSI
Greenwich Lifesciences Inc
9.82 123.97M 0 -8.89M -6.48M -0.70
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.48 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
605.01 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.82 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
252.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
249.94 24.70B 3.81B -644.79M -669.77M -6.24

Greenwich Lifesciences Inc Stock (GLSI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-09-01 Eingeleitet H.C. Wainwright Buy

Greenwich Lifesciences Inc Aktie (GLSI) Neueste Nachrichten

pulisher
Apr 24, 2025

HC Wainwright Issues Pessimistic Estimate for GLSI Earnings - Defense World

Apr 24, 2025
pulisher
Apr 22, 2025

Greenwich LifeSciences (NASDAQ:GLSI) Price Target Raised to $39.00 at HC Wainwright - Defense World

Apr 22, 2025
pulisher
Apr 21, 2025

Greenwich LifeSciences stock target raised to $39 at H.C. Wainwright By Investing.com - Investing.com Canada

Apr 21, 2025
pulisher
Apr 21, 2025

H.C. Wainwright Boosts Greenwich LifeSciences (GLSI) Price Target Amid Promising Trial Results | GLSI Stock News - GuruFocus

Apr 21, 2025
pulisher
Apr 16, 2025

(GLSI) Proactive Strategies - news.stocktradersdaily.com

Apr 16, 2025
pulisher
Apr 15, 2025

Greenwich Lifesciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Apr 15, 2025
pulisher
Apr 15, 2025

Greenwich LifeSciences, Inc. SEC 10-K Report - TradingView

Apr 15, 2025
pulisher
Apr 14, 2025

Greenwich LifeSciences (GLSI) Expected to Announce Earnings on Monday - Defense World

Apr 14, 2025
pulisher
Apr 12, 2025

GREENWICH LIFESCIENCES Earnings Preview: Recent $GLSI Insider Trading, Hedge Fund Activity, and More - Nasdaq

Apr 12, 2025
pulisher
Apr 11, 2025

Greenwich Lifesciences Inc expected to post a loss of 21 cents a shareEarnings Preview - TradingView

Apr 11, 2025
pulisher
Apr 08, 2025

Greenwich Lifesciences CEO Snehal Patel acquires $32,760 in stock - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

Greenwich Lifesciences CEO Snehal Patel acquires $32,760 in stock By Investing.com - Investing.com UK

Apr 08, 2025
pulisher
Apr 07, 2025

Greenwich LifeSciences CEO Snehal Patel buys $48,015 in common stock By Investing.com - Investing.com Canada

Apr 07, 2025
pulisher
Apr 07, 2025

Greenwich LifeSciences CEO Snehal Patel buys $48,015 in common stock - Investing.com Australia

Apr 07, 2025
pulisher
Apr 03, 2025

Investigative Agent Elicits Responses in Phase 3 Breast Cancer Trial - Curetoday

Apr 03, 2025
pulisher
Apr 03, 2025

Greenwich LifeSciences reports progress on FLAMINGO-01 trial By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

GLSI stock touches 52-week low at $9.05 amid market challenges By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

GLSI stock touches 52-week low at $9.05 amid market challenges - Investing.com

Apr 03, 2025
pulisher
Apr 03, 2025

Greenwich Lifesciences Provides Global Update On Flamingo-01 - marketscreener.com

Apr 03, 2025
pulisher
Apr 03, 2025

Greenwich LifeSciences Provides Global Update on FLAMINGO-01 - GlobeNewswire

Apr 03, 2025
pulisher
Apr 03, 2025

Greenwich LifeSciences reports progress on FLAMINGO-01 trial - Investing.com

Apr 03, 2025
pulisher
Apr 03, 2025

Major Breakthrough: Cancer Prevention Trial Reports Positive Data, Elite Hospitals Join - Stock Titan

Apr 03, 2025
pulisher
Apr 02, 2025

Greenwich LifeSciences (GLSI) Shares Surge on Positive Phase 3 D - GuruFocus

Apr 02, 2025
pulisher
Apr 02, 2025

Flamingo cancer vaccine in phase III pink, Greenwich time nigh? - BioWorld MedTech

Apr 02, 2025
pulisher
Apr 02, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Apr 02, 2025
pulisher
Apr 02, 2025

Greenwich LifeSciences stock rises on cancer shot data (GLSI) - Seeking Alpha

Apr 02, 2025
pulisher
Apr 02, 2025

Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial - The Manila Times

Apr 02, 2025
pulisher
Apr 02, 2025

Greenwich Lifesciences Announces Positive Immune Response Data From FLAMINGO-01 Phase III Clinical Trial - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

Clinical Trial Success: GLSI's Breast Cancer Therapy Shows Promising Results in Expanded Patient Group - Stock Titan

Apr 02, 2025
pulisher
Apr 02, 2025

Greenwich LifeSciences (NASDAQ:GLSI) Trading Down 6.7%Time to Sell? - MarketBeat

Apr 02, 2025
pulisher
Apr 01, 2025

Recent 15% decline may not have gone down well with Greenwich LifeSciences, Inc. (NASDAQ:GLSI) insiders who've been purchasing recently - simplywall.st

Apr 01, 2025
pulisher
Mar 31, 2025

Greenwich LifeSciences Delays Yearly Report Filing - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

How To Trade (GLSI) - news.stocktradersdaily.com

Mar 31, 2025
pulisher
Mar 27, 2025

Greenwich LifeSciences Extends Lock-Up Period for Directors, Officers to March 2026 - MarketScreener

Mar 27, 2025
pulisher
Mar 27, 2025

Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026 - GlobeNewswire

Mar 27, 2025
pulisher
Mar 27, 2025

Major Insider Confidence Signal: Greenwich LifeSciences Leadership Locks Shares Until 2026 - Stock Titan

Mar 27, 2025
pulisher
Mar 26, 2025

HER2-Positive Breast Cancer Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Roche Pharma AG, Dizal Pharma, Greenwich LifeSciences, Ambrx, Alteogen - Barchart

Mar 26, 2025
pulisher
Mar 26, 2025

HER2-Positive Breast Cancer Pipeline 2025: Therapies, MOA - openPR.com

Mar 26, 2025
pulisher
Mar 25, 2025

GLSI stock touches 52-week low at $10.52 amid market challenges - Investing.com

Mar 25, 2025
pulisher
Mar 17, 2025

Greenwich LifeSciences gets DSMB approval to continue late-stage trial of GLSI-100 - MSN

Mar 17, 2025
pulisher
Mar 17, 2025

Greenwich LifeSciences Says Preliminary Safety Data for Breast Cancer Therapy Appears Consistent With Prior Trials - Marketscreener.com

Mar 17, 2025
pulisher
Mar 17, 2025

Greenwich LifeSciences reports positive safety data on GLSI-100 - Investing.com India

Mar 17, 2025
pulisher
Mar 17, 2025

Greenwich LifeSciences reports positive safety data on GLSI-100 By Investing.com - Investing.com UK

Mar 17, 2025
pulisher
Mar 17, 2025

Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01 - GlobeNewswire

Mar 17, 2025
pulisher
Mar 10, 2025

Trading (GLSI) With Integrated Risk Controls - news.stocktradersdaily.com

Mar 10, 2025
pulisher
Mar 05, 2025

Non-Small Cell Lung Cancer Clinical Trial Pipeline | 100+ Companies Pioneering the Future of Treatment - openPR

Mar 05, 2025
pulisher
Mar 05, 2025

55% of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) is owned by insiders, and they've been buying recently - Yahoo Finance

Mar 05, 2025
pulisher
Feb 27, 2025

Learn to Evaluate (GLSI) using the Charts - news.stocktradersdaily.com

Feb 27, 2025
pulisher
Feb 22, 2025

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Sees Large Increase in Short Interest - MarketBeat

Feb 22, 2025
pulisher
Feb 21, 2025

Short Interest in Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Increases By 5.1% - MarketBeat

Feb 21, 2025
pulisher
Feb 20, 2025

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Verra Mobility Corporation (NASDAQ: VRRM) - PR Newswire

Feb 20, 2025

Finanzdaten der Greenwich Lifesciences Inc-Aktie (GLSI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.65
price up icon 0.63%
$70.47
price up icon 1.28%
$32.49
price up icon 0.64%
$23.90
price up icon 1.85%
$108.35
price up icon 3.89%
biotechnology ONC
$247.87
price up icon 1.21%
Kapitalisierung:     |  Volumen (24h):